The Riverside Co. announced the signing of a definitive agreement to acquire a majority stake in BioDue SpA, an Italian manufacturer of dietary supplements, medical devices and cosmetics.
Terms of the agreement, which is subject to regulatory approvals, were not disclosed.
Founded in 1986 by the Benedetti family, BioDue is described as one of Italy’s leading suppliers of dietary supplements and medical devices.
“The company offers its customers a full service offering, from development and formulation to raw material sourcing, production, packaging and regulatory affairs to commercialization,” according to Riverside. “BioDue has a high-quality customer base, including some of Europe’s largest pharmaceutical and nutraceutical companies, as well as five well-invested manufacturing sites.”
Riverside points to the deal as one of many in its interest for specialty companies operating in areas such as healthcare and consumer products and services.
“In addition to pursuing complementary acquisitions and helping the company grow its product line, we also plan to enhance BioDue’s business approach to accelerate sales growth and drive operational excellence,” added Rafael Alvarez-Novoa, partner of Riverside Europe.
Riverside is a Cleveland-based global private equity firm that invests in growth companies worth up to $400 million in the small segment of the middle market.